Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.
Maurer M, Eyerich K, Eyerich S, Ferrer M, Gutermuth J, Hartmann K, Jakob T, Kapp A, Kolkhir P, Larenas-Linnemann D, Park HS, Pejler G, Sánchez-Borges M, Schäkel K, Simon D, Simon HU, Weller K, Zuberbier T, Metz M. Maurer M, et al. Among authors: gutermuth j. Int Arch Allergy Immunol. 2020;181(5):321-333. doi: 10.1159/000507218. Epub 2020 Mar 30. Int Arch Allergy Immunol. 2020. PMID: 32224621 Free PMC article. Review.
Mouse models of atopic eczema critically evaluated.
Gutermuth J, Ollert M, Ring J, Behrendt H, Jakob T. Gutermuth J, et al. Int Arch Allergy Immunol. 2004 Nov;135(3):262-76. doi: 10.1159/000082099. Epub 2004 Nov 10. Int Arch Allergy Immunol. 2004. PMID: 15542938 Review.
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines.
Agache I, Song Y, Posso M, Alonso-Coello P, Rocha C, Solà I, Beltran J, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Werfel T, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Among authors: gutermuth j. Allergy. 2021 Jan;76(1):45-58. doi: 10.1111/all.14510. Epub 2020 Oct 4. Allergy. 2021. PMID: 32691892
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines.
Agache I, Rocha C, Pereira A, Song Y, Alonso-Coello P, Solà I, Beltran J, Posso M, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong P, O'Mahony L, Schwarze J, Werfel T, Canelo-Aybar C, Palomares O, Jutel M. Agache I, et al. Among authors: gutermuth j. Allergy. 2021 Jan;76(1):59-70. doi: 10.1111/all.14547. Epub 2020 Sep 7. Allergy. 2021. PMID: 32767573
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.
Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. Agache I, et al. Among authors: gutermuth j. Allergy. 2021 Apr;76(4):988-1009. doi: 10.1111/all.14690. Epub 2020 Dec 27. Allergy. 2021. PMID: 33538044
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old.
Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. Agache I, et al. Among authors: gutermuth j. Allergy. 2022 Jan;77(1):17-38. doi: 10.1111/all.15030. Epub 2021 Aug 8. Allergy. 2022. PMID: 34324716
A Novel Method for Total IgE Purification from Human Serum.
Badloe FMS, De Vriese S, De Bruyn Carlier T, Vandersichel E, Scheffel J, Maurer M, Ring J, Gutermuth J, Kortekaas Krohn I. Badloe FMS, et al. Among authors: gutermuth j. J Immunol. 2022 May 15;208(10):2436-2442. doi: 10.4049/jimmunol.2100497. Epub 2022 May 6. J Immunol. 2022. PMID: 35523453
103 results